Background: Treatment of heart failure by surgical procedures such as mitral annuloplasty and left ventricular (LV) restoration is increasingly applied to patients with ischemic mitral regurgitation (IMR) and LV dysfunction. The clinical efficacy of delayed enhancement magnetic resonance imaging (DE-MRI) was studied to predict LV functional recovery and adverse outcomes after these therapies.
ost infarction left ventricular (LV) remodeling characterized by chamber dilatation and abnormal geometric change leads to the enhancement of functional ischemic mitral regurgitation (IMR). 1 This condition results in further heart failure progress and is associated with a high morbidity and mortality when treated conservatively, even when there is mild IMR in patients with dysfunctional LV. 2 As a surgical strategy for IMR and dysfunctional LV, recent studies demonstrated the efficacy of surgical therapies including restrictive mitral annuloplasty, and LV restoration in addition to coronary artery bypass grafting (CABG). [3] [4] [5] [6] [7] Useful prognostic markers including LV volume or dimension have been used to elucidate the risk stratification in patients who undergo these surgical therapies; 4-7 however, there are many conflicting reports and so far no conclusive data exists. Moreover, because patients with heart failure often show varying patterns of scarring despite similar degrees of myocardial dysfunction, 8 limitations of these surgical therapies in terms of survival benefits 9,10 might be partly associated with marked heterogeneity regarding the essential myocardial status in each patient. Therefore, we hypothesized that the fundamental myocardial status might be the most essential factor to identify patients not likely to benefit from these surgical therapies.
To predict whether regional myocardium remains hibernating or has been irreversibly damaged, delayed enhancement magnetic resonance imaging (DE-MRI) is gaining widespread use because the amount of myocardial scarring
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exhibited by DE-MRI is inversely proportional to the recovery of myocardial systolic thickening after revascularization. 11 Consequently, DE-MRI might become an important diagnostic tool to identify a subset of ischemic heart failure patients likely to benefit from surgical theparies. 12, 13 However, there are few DE-MRI studies to focus on patients with IMR undergoing surgical therapies. This study was designed to investigate the utility of scar imaging by DE-MRI to predict a response to surgical therapies in patients with IMR and dysfunctional LV.
Methods

Patients
Ethical committee approval was obtained for this retrospective study. We included 26 consecutive patients (20 men, 6 women, age 65±9.4 years, range 45-81 years) who underwent a DE-MRI study for the assessment of myocardial status before the operation between January 2005 and February 2009. For inclusion in the study, patients were required to have coronary artery disease confirmed by a catheterization, congestive heart failure symptoms, LV ejection fraction (LVEF <40%), and more than 2+ IMR, preoperatively. The etiology and degree of mitral regurgitation was precisely determined by a preoperative echocardiogram. Patients who had acute myocardial infarction within 1 month, mitral regurgitation related to organic mitral valve disease, a LVEF >40%, and standard contraindications to MRI imaging were excluded from this study. Table 1 shows the preoperative clinical profiles of the patients.
Surgical Planning and Operative Variables
Our surgical principles during this study period were as follows. CABG is performed with the aim of complete revascularization with the predominant use of the internal mammary artery. The mitral valve was exposed via the left atriotomy and the stringent restrictive mitral annuloplasty was performed with the complete semi-rigid ring (Carpentier Edwards Physio ring; Edward Lifesciences, Irvine, CA, USA). The size of the annuloplasty ring used was 24 mm in 7 (29%) and 26 mm in 19 (71%) patients. CABG was performed in 17 (65%) patients with a mean distal anastomosis of 2.8±1.5. Nine patients (35%) had already undergone revascularization either surgically (n=2) or percutaneously (n=7). Concomitant LV restoration by means of the modified Dor-type procedure was applied to patients who had both non-viable antero-septal scarring on DE-MRI and dilated LV, as previously described. 13 Other operative variables were listed in Table 1 .
MRI Protocol and Image Analysis
MRI images were acquired on a commercially available 1.5-tesla imager (GE Healthcare) using a phased-array coil with repeated breath-holding and retrospective-electrocardiogram triggered gating. Steady-state free precession cine images were acquired in multiple short axes (every 8 mm throughout the entire LV). Temporal resolution of cine images ranged from 30 to 50 ms. The myocardial borders were planimetered on all the short-axis cine images to determine LV function. Gadolinium (gadolinium-DTPA, 0.2 mmol/kg) was administered intravenously and 8-12 DE images, depending on the cardiac size, were acquired after 15 min with a segmented inversion-recovery technique in the identical planes. 14 Our cohort included patients who underwent LV restoration in whom the importance of myocardial status on DE-MRI had been reported by us. 13 That study, however, was limited because of the small number of patients with IMR and the myocardial assessment was only conducted at the basilar portion. In this study, to examine the regional heterogeneity of scarred myocardium in each patient and elucidate its impact on postoperative outcomes, we evaluated the regional myocardial scarring at the basal, mid and apical LV according to standardized LV segmentation. 15 The hyperenhancement area was defined as the region with a signal intensity at least 2 standard deviation (SD) above a reference normal myocardial region. 16 The hyperenhancement regions were automatically contoured and its area was calculated at each region. We expressed the hyperenhancement area as a percentage of the LV area (percentage of fibrosis) at each region. Image analyses were verified by a single experienced observer (S.H.) blinded to clinical outcomes and results of the other parameters measured.
Postoperative Medical Regimens
All patients received a heart failure medical treatment regimen including β-blocker, angiotensin-converting enzyme inhibitor or angiotension II receptor blockers, and spironolactone.
Assessment of Pre and Postoperative LV Function and Hemodynamics
Cine MRI was used to calculate global LV volumes and LVEF preoperatively and was repeated at the mean of 1 month after the operation. Pre and postoperative right heart catheterization was used to measure mean pulmonary artery pressure (PAP) and cardiac index before and within 30 days after the operation. Pre and postoperative LV end-systolic TAKEDA K et al.
and -diastolic dimensions and fractional shortening were measured by standard transthoracic echocardiographic examinations at almost the same timing as the MRI study. The severity of mitral regurgitation was qualitatively graded on a scale of 0 to 4+. To evaluate the diastolic LV function, the early to late mitral valve flow ratio (E/A) and deceleration time (DT) was measured in patients without atrial fibrillation.
Patients with postoperative restrictive filling were defined as those with an E/A >1.5, and a DT <140 ms. 17 An echocardiographic study was repeated at a later postoperative period in 16 patients (6 months to 1 year after the operation).
Neurohormonal Assessment
As a neurohormonal assessment, serum brain natriuretic peptide (BNP) was also measured at the time of the MRI study.
Statistical Analysis
The SPSS (version 11.0; SPSS Inc, Chicago, IL, USA) software was used for statistical analyses. The quantitative data were presented as mean ± SD. Values obtained from pre-and postoperative data were compared by a paired t-test. The Friedman test was used to compare 3 paired groups. The continuous variables were compared using linear regression analysis. Logistic regression analysis was performed to clarify the independent pre-and intra-operative variables on late adverse outcome. Because of the low number of patients and few adverse events, preoperative variables with a statistical significance as assessed by univariate comparison were used in the multivariate analysis. The cut-off value of percentage of fibrosis to predict adverse outcomes was determined by receiver-operating characteristic curve analysis. Statistical significance was defined as a P-value less than 0.05.
Results
DE-MRI Findings
Overall, 23 of 26 patients (88%) had evidence of scarring in at least 1 region on DE-MRI imaging. Quantitatively, the average degree of regional percentage of fibrosis in all patients was 12±12% at the base, 24±15% at the mid, and 35±31% at the apical LV. There were significant correlations between basal and mid fibrosis (r=0.68, P=0.0002), and mid and apical fibrosis (r=0.72, P<0.0001). Distribution of myocardial scarring was depending on the culprit coronary artery (Figure 1 ). According to the standardized LV segmentation model, 15 
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myocardial scarring was identified at the left anterior descending territory in 9, circumflex or right coronary artery territory in 6, and multi-arterial (more than 2 coronary artery territories) territory in 8 patients. Particularly, patients with multiterritory myocardial infarction had a significantly greater degree of regional fibrosis than those with scarring at a single artery territory at the basal (27±8.0% vs. 6.5±6.9%, P<0.001), and mid (39±8.5% vs. 21±11%, P=0.002) regions, although no statistically significant difference was found at the apical region (49±24% vs. 30±32%, P=0.19). Tables 1,2. TAKEDA K et al.
Impact of Regional Fibrosis on Early Change of LV Function and Hemodynamics
Changes of functional class, LV function, hemodynamics, degree of mitral regurgitation, and BNP level are listed in Table 2 . The mean change of LVEF was +9.4±8.1%. The degree of LV functional recovery was not statistically different between patients with simultaneous CABG and those without it; percentage reduction in LVEDVI (31% vs. 34%, P=0.55) and in LVESVI (41% vs. 38%, P=0.65), and the mean increase in LVEF (11% vs. 5.6%, P=0.08). When we investigated the LV functional recovery according to patients with or without LV restoration, no significant differences were found between the 2 groups; percentage reduction in LVEDVI (36% vs. 28%, P=0.22) and in LVESVI (41% vs. 39%, P= 0.65), and mean increase in LVEF (7.6% vs. 11%, P=0.18). On echocardiogram, the mean postoperative E/A and DT were 1.7±0.9 and 220±72 ms, respectively. Nine patients were identified as having restrictive LV filling, postoperatively. Table 3 demonstrates the pre-and intra-operative risk factors for less improvement in LVEF (change of LVEF less than the mean value; n=14) and postoperative LV restrictive filling (E/A >1.5, DT <140 ms; n=9) by logistic regression analysis. By univariate comparisons, significant predictors for both categories included the degree of basal fibrosis and mean PAP, although subsequent multivariate analysis failed to elucidate any significant variables because of significant collinearity between the 2 parameters (r=0.59, P=0.002). Neither mid-or apical fibrosis nor additional surgical procedures including CABG, LV restoration, maze procedure, and tricuspid annuloplasty related to postoperative systolic and diastolic impairment. Because the basilar myocardial status was likely to be an important predictor of impaired systolic and diastolic function after surgery, we investigated the relationship between percentage of basal fibrosis and postoperative LV measurements and hemodynamic variables. There were significant correlations between degree of basal fibrosis and postoperative LVEF (Figure 2a) . Furthermore, significant correlations were noted between basal fibrosis and postoperative diastolic parameters including mean PAP and the mitral inflow indices (Figures 2b-d) .
Impact of Regional Fibrosis on Clinical Outcomes
All patients tolerated the operation and there was no 30-day mortality. During a mean follow up of 21 months, 2 patients died of recurrent heart failure and cerebral hemorrhage associated with infective endocarditis, respectively. Other major adverse cardiac events occurred in 5 patients; recurrent congestive heart failure (n=3), ventricular tachycardia requiring implantable cardioverter-defibrillator (n=1), mitral valve replacement for infective endocarditis (n=1). The other 
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patients were well and in NYHA functional class II or I. Table 4 demonstrates the results of logistic regression analysis to elucidate the predictor for postoperative adverse outcomes, except for infective endocarditis, including early and late postoperative recurrent heart failure and fatal arrhythmia. Univariate pre-and intra-operative predictors included LV diastolic/systolic dimension and degree of basal fibrosis. Subsequent multivariate analysis demonstrated that the degree of basal fibrosis was the only statistically significant predictor for adverse outcomes (P=0.04, odds ratio 1.26, 95% confidence interval 1.01-1.58). Receiver-operating characteristic curve analysis showed that the cut-off value for degree of basal fibrosis to predict adverse outcomes was 16.5%, with a predictive sensitivity of 85.7% and a specificity of 84.2% (area under the curve 0.91). Figure 3 demonstrates the individual degree and location of basal fibrosis on DE-MRI. None of the patients without basal scarring (n=9) had late adverse events. On the contrary, 3 out of 6 patients (50%) with multi-territory basal scarring had major adverse outcomes. Regarding the transmural extent of basal myocardial scarring, no patients had transmural basal scarring at the left anterior descending territory in our cohort; however, 4 patients had large transmural basal scarring at the circumflex or right coronary artery territory (Figure 3, asterisk) . Three of those (75%) experienced late adverse outcomes.
Impact of Basal Fibrosis on Late Echocardiographic Results
In patients who underwent a serial echocardiographic study, 3 out of 16 patients developed 2+ recurrent mitral regurgitation. Although those had a relatively greater degree of basal fibrosis compared with patients without recurrent mitral regurgitation (16±13% vs. 8.9±12%), the difference did not reach statistical significance (P=0.3). In this cohort, no significant predictors were identified for recurrent regurgitation. Late LV end-diastolic and -systolic dimensions were 58±6.6 and 48±8.4 mm, respectively. Thus, the improvement in LV dimension had sustained at the later period. To assess the impact of regional fibrosis on late reverse remodeling within the region that could not be modulated by LV restoration, we investigated the relationship between degree of basal fibrosis and percentage late reduction in end-diastolic and -systolic dimension, calculated relative to preoperative one. A significant correlation was observed between the 2 parameters (Figure 4) .
Discussion
This study indicates that the extent of LV fibrosis on DE-MRI might provide an additive value to predict a response to surgical heart failure therapies including restrictive mitral Tables 1-3. TAKEDA K et al.
annuloplasty, and LV restoration, in addition to CABG in patients with IMR and dysfunctional LV. Simple LV measurements such as LV volume, dimension, and LVEF do not contain information about the fundamental ventricular pathology, therefore, the issues about the myocardial viability should be clarified because IMR is a sequence of ventricular problems. 1 Although the acceptable early results with the significant improvements of LV function, symptoms, and decrease of BNP level were achieved in our population, these therapies do not ensure significant LV systolic and diastolic improvements in patients with more extensive fibrosis, indicating that preoperative heterogeneity of myocardial status is the most important factor to predict the outcomes.
Why does basal fibrosis rather than mid or apical fibrosis have a significant impact on postoperative outcomes? Considering the coronary anatomy, myocardial infarction usually extends from the basal to the apical area when the right or circumflex artery is the culprit. Proximal anterior descending artery occlusion results in extensive antero-septal myocardial injury toward the LV base from the apex. Evidently, our quantification demonstrated the significant relevance between basal and mid and apical fibrosis. Moreover, the transmural extent of basal scarring was clearly evident in patients with right or circumflex myocardial infarction. Therefore, basal myocardial injury represents the extension of global myocardial injury leading to systolic and Figure 3 . Individual degree and location of basal fibrosis according to the territory of the coronary artery system. All patients with MT basal infarction had both subendocardial scarring at the LAD territory and the various extent of scarring at the RCA and/or Cx territories. Four patients had large transmural basal scarring at the RCA and/or Cx territory (asterisk). LAD, left anterior descending artery; MT, multiterritory; RCA, right coronary artery; Cx, circumflex artery; MACE, major adverse cardiac events. 
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diastolic impairment. As a consequence, the presence of more extensive basal fibrosis leads to a substantial risk of adverse clinical outcomes especially in patients with multiterritory and transmural lateral or infero-posterior basal scarring (Figure 3) .
The basal portion of the LV is connected with longitudinal subendocardial muscle fibers that are sensitive to pathological conditions including ischemia and infarction as compared with the apical portion. 18 Fuchs et al demonstrated that increases of basal myocardial performance, rather than those of the apical area, resulted in improvement in global LV systolic function after medical heart failure therapy. 19 There are increasing evidences that the degree of segmental velocities of basal myocardium assessed by tissue Doppler imaging provides a strong predictor for morbidity and mortality in heart failure patients including ischemic etiology. 20 These studies are based on the fact that the basal portion of the LV displays the highest velocities within the heart, and is an important component of LV systolic function. It is therefore reasonable that the more extensive basal fibrosis might lead to a reduced recovery of LV systolic function.
The development of diastolic dysfunction is one of the concerning issues after these surgical therapies. Although annular reshaping by restrictive annuloplasty did not induce an acute change in LV diastolic performance, the later fate of LV diastolic property is still unknown. 21 Moreover, the size of the residual LV cavity after LV restoration might cause a greater concern with an increased risk of LV diastolic dysfunction. 10 We found that the mean PAP was reduced soon after the operation, probably originating from the disappearance of IMR. However, more extensive myocardial fibrosis carries postoperatively a higher PAP and restrictive mitral inflow pattern as the representative of LV diastolic impairment. Because LV diastolic function is an important pathogenesis of heart failure symptoms, 22 the prediction of postoperative diastolic function is clinically relevant. Previous studies suggested that diastolic function assessed by mitral flow indices provided additional prognostic information in patients undergoing either LV restoration or RMA. 23, 24 However, no reports exist about the correlation between LV myocardial status and these indices. Because there are many evidences showing the relationship between LV stiffness and myocardial scarring in patients with LV dysfunction, 25 our results indicate that the degree of basal fibrosis represents the intrinsic LV stiffness composing postoperative diastolic function.
Although the late echocardiographic study was performed with a limited number of patients, our study demonstrated that late reverse ventricular remodeling was also associated with the myocardial status. The ultimate goal of surgical therapies for IMR is to promote LV reverse remodeling by reducing the volume overload, whereas a persistent or progressive remodeling pattern has been documented despite an initially successful mitral repair. 5, 26 Braun et al showed that a preoperative LV diastolic dimension less than 65 mm was a significant predictor for reverse LV remodeling. 4 The relationship between basal fibrosis and reduction in end-systolic dimension in our study explained that the lack of reverse remodeling in patients with a larger preoperative LV dimension might be partly related to the existing irreversible ischemic myocardial damage. Although our study did not elucidate the impact of regional scarring on recurrent mitral regurgitation because of a low number of cohorts and a relatively low recurrent rate, the issue about late recurrence of IMR requires further investigation because the problem about the high recurrent rate related to the lack of LV reverse remodeling after annuloplasty procedure has still been debated. 26 
Study Limitations
There are several limitations in this study. The number of patients is low, therefore, our results might not have strong power to draw a definitive conclusion. However, our results implied that the preoperative myocardial assessment is the most important when we consider surgical therapies for IMR and LV dysfunction.
The diversity of surgical procedures added, especially with or without CABG and/or LV restoration procedure, is one of the major limitations in this study. Although our analysis demonstrated no significant impact of simultaneous CABG on early improvement in LV function, recent studies indicated the time-course of long-term LV functional recovery after revascularization in patients with LV dysfunction. 27 Therefore, the effect of simultaneous CABG might become apparent and have an influence on late clinical outcomes with further follow up. With regard to the effect of LV restoration, although our study demonstrated no impact of preoperative degree of mid-and apical fibrosis on outcomes, this was partly attributed to the fact that surgical exclusion of antero-septal scarring could diminish their effects in the LV restoration group. Indeed, patients undergoing LV restoration had a significantly greater degree of preoperative mid-(36±7.8% vs. 11±9.8%, P<0.001) and apical (59±20% vs. 8.8±9.1%, P<0.001) fibrosis than those without LV restoration due to the extensive transmural antero-septal scarring, indicating more advanced intrinsic myocardial disease. Nonetheless, the degree of postoperative LV functional recovery was similar between the groups, suggesting the certain impact of the LV restoration procedure at least on the LV functional change, as evidenced by a recent randomized trial. 10 Moreover, we believe that similar extent of basal scarring between patients with LV restoration and those without it (15±14% vs. 8.7±9.4%, P=0.17) was also responsible for the similar degree of LV functional recovery in both groups. Therefore, regardless of procedures (with or without LV restoration), assessment of basal myocardial status is feasible when we consider surgical therapies for patients with IMR and LV dysfunction. Other surgical procedures including tricuspid annuloplasty and maze procedure had the same limitation, although a small number in the cohort did not allow us to make a direct comparison of each category of patient. Current therapies for post-infarction heart failure require a combination of a number of surgical interventions and medical treatments to maximize the clinical benefits. 28 Therefore, we think that it is difficult to exclusively investigate the effect of each therapy in the clinical setting.
We evaluated the regional scarring at 3 representative parts of the LV, because this can be directly translated into clinical practice. However, because of a limited number of slices analyzed, some detail might be lost. Flynn et al recently reported the importance of papillary muscle scar burden to identify patients for whom annuloplasty alone is insufficient to prevent recurrent regurgitation. 29 Further investigation such as 3-dimensional analyses might be more informative to determine whether the precise amount or location of hyperenhancement tissue predicts adverse outcomes.
Conclusions
In conclusion, the amount of LV basal scarring affected both TAKEDA K et al.
postoperative LV systolic and diastolic function and therefore might impact on adverse outcomes after surgical therapies in patients with IMR and LV dysfunction. Patients who have a large amount of LV basal scar are likely to be a highrisk group. Although further investigation, including a larger population, should be performed, preoperative assessment of myocardial status on DE-MRI might be useful to predict adverse outcomes.
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